Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its product candidate includes RP-G28.
| Website: | www.ritterpharmaceuticals.com |
| Main Phone: | +1 310 203-1000 |
| Address: | 1880 Century Park East |
| Address 2: | Suite 1000 |
| State: | CA |
| City / Town: | Los Angeles |
| Country: | USA |
| Postal Code: | 90067 |
| Exchange: | NSC |
| Employees: | 8 |
| NAICS: | Pharmaceutical P |
| Last Price 0.57 | Change $ -0.0276 | Change % -4.60 | Tick N/A |
| Bid 0.56 | Bid Size 4,500.00 | Ask 0.57 | Ask Size 100.00 |
| Open 0.60 | High 0.60 | Low 0.55 | Prev Close 0.60 |
| Last Trade | Volume 63,112 | 52 Wk Hi 3.75 | 52 Wk Low 0.50 |
| Market Cap 8.4 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 14,756,521.00 | EPS (TTM) -1.47 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 4 |
| Number of Buys | 0 | 4 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 52500 |
| Last 10 Buys | Shares |
|---|---|
| Ira E. Ritter | 1,000 |
| Andrew J. Ritter | 1,000 |
| Matthew W. Foehr | 1,000 |
| Michael D. Step | 1,000 |
| Noah J. Doyle | 1,000 |
| Matthew W. Foehr | 1,000 |
| Gerald T. Proehl | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 7 | 7 | 7 | 7 |
| Low Target Price Estimate | 3 | 3 | 3 | 3 |
| Mean Target Price Estimate | 5.33 | 5.67 | 5.67 | 5.33 |
| Standard Deviation | 2.08 | 2.31 | 2.31 | 2.08 |
| Date of Most Recent Estimate | 08/15/16 | 06/21/16 | 06/21/16 | 08/23/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-08-23 |
| S-3 | Simplified registration form | 126 | 2016-08-11 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 41 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-07 |
| S-8 | Securities offered to employees under employee benefit plans | 37 | 2016-06-16 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-06-07 |
| 8-K | Report of unscheduled material events or corporate changes. | 9 | 2016-06-06 |
| POS AM | Post-effective amendment to an S-Type filing | 38 | 2016-06-01 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
